Study of Amino Acid Supplementation for Patients With an Excessive Loss of Muscular Body Mass After Obesity Surgery. (MUSCAADE)
Primary Purpose
Obesity
Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Leucine-enriched amino acid supplementation and 30 minutes of physical training 3 times per week
Sponsored by

About this trial
This is an interventional supportive care trial for Obesity focused on measuring Post-obesity surgery, Leucine-enriched amino acid supplementation, Anabolic substance, Physical training, Muscular mass, Loss of weight
Eligibility Criteria
Inclusion Criteria:
- Patient older than 18 years of age and younger than 65 years of age,
- Patient received an obesity-surgery (gastric bypass or sleeve gastrectomy)
- Contribution of muscular weight higher than 15% of the total weight loss after the third month post-surgery.
- Patient that be able to increase their physical activity
- Patient that give their informed consent before any procedure for the study
- Patient affiliated with a health insurance scheme
Exclusion Criteria:
- Patients allergic to one of the supplement's compound.
- Patients with glucocorticoid therapy
- Patients with hyperthyroidism
- Patients commencing insulin treatment or growth hormone
- Protein powder intake (as nutritional complement or as anabolic substance for muscle building practice)
- Oral nutritional supplement intake for malnutrition
- Bone fracture since the surgery
- Infection can cause hypercatabolism (like microbial outbreak or chronic gastric fistula)
- Hospitalization for more than 24 hours since the surgery
- Known physical handicap
- Inability to increase physical activity during 3 months after beginning of the supplementation
- Enteral or parenteral nutrition
- Patients over 158 kg (DEXA impossible)
- Protected adults (guardianship by court order)
- Pregnant woman or breastfeeding.
Sites / Locations
- Department of Endocrinology, metabolic diseases and nutrition
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Leucine-enriched amino acid : 2.16g/day
Leucine-enriched amino acid : 4g/day
Arm Description
Dietary Supplement: Leucine-enriched amino acid supplementation and 30 minutes of physical training 3 times per week (2.16g/day)
Dietary Supplement: Leucine-enriched amino acid supplementation and 30 minutes of physical training 3 times per week (4g/day).
Outcomes
Primary Outcome Measures
Change from baseline in appendicular muscular mass at 3 months
Appendicular muscular mass measured by dual-energy X-ray absorptiometry (DEXA). It will be measured before and 3 months after supplementation.
Secondary Outcome Measures
Change from baseline in limbs muscular force at 3 months
The lower and higher limbs muscular force will be measured with a strain gauge.
Change from baseline in muscular function at 3 months
400 meters walking speed
Change from baseline in muscular function at 3 months
Chair-stand test
Change from baseline in muscular function at 3 months
Balance test by the Short Physical Performance Battery test
Change from baseline in fatigue at 3 months
Fatigue will be evaluate by the Pichot scale
Change from baseline in general functional assessment at 3 months
General function will be assessed by the Functional Status Questionnaire test.
Change from baseline in protein daily intake at 3 months
Patient will evaluate his/her protein daily intake (in g/day) by the Protein Intake Monitor with a digital tablet
Change from baseline in physical training adhesion at 3 months
Patients will have an exercise diary to write their organised physical activity. Physical activity will be converted in a multiple of basal metabolic rate.
Change from baseline in glucose metabolism at 3 months
Oral glucose tolerance test will be performed and glucose concentration will be determined into the blood.
Change from baseline in insulin secretion at 3 months
Oral glucose tolerance test will be performed and insulin concentration will be determined into the blood.
Change from baseline in leucine compliance
Leucine concentration and variation between visit before and after 3 months of supplementation will be measured by chromatography to assess the patient's compliance
Full Information
NCT ID
NCT02716740
First Posted
March 9, 2016
Last Updated
April 1, 2019
Sponsor
University Hospital, Toulouse
1. Study Identification
Unique Protocol Identification Number
NCT02716740
Brief Title
Study of Amino Acid Supplementation for Patients With an Excessive Loss of Muscular Body Mass After Obesity Surgery.
Acronym
MUSCAADE
Official Title
Pilot Study of Branched Amino Acid Supplementation for Patients With an Excessive Loss of Muscular Body Mass After Obesity Surgery.
Study Type
Interventional
2. Study Status
Record Verification Date
April 2019
Overall Recruitment Status
Terminated
Why Stopped
not enough patient
Study Start Date
February 8, 2017 (Actual)
Primary Completion Date
July 13, 2017 (Actual)
Study Completion Date
July 13, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Toulouse
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Despite the demonstrable health and quality of life benefits, there are unknowns within consequences of obesity surgery. Weight loss composition is poorly understood. The objective is to have a significant loss of body fat and a limited loss of muscular weight.
A cohort study in the nutrition unit at Toulouse University Hospital shows that 3 months and 1 year after surgery, there are 2 phenotypes of patients. The first one is called 'little loss' and is defined by a contribution of muscular weight lower than 15% of the total weight loss. The other one is called 'big loss' and is defined by a contribution of muscular weight higher than 15% of the total weight loss. Causes of these different phenotypes are unknown for the moment.
Some amino acids have an anabolic potential. Leucine induces a muscular protein synthesis in clinical situations like hepatic cirrhosis, and some populations like new born and older people.
Assuming that, a leucine-enriched essential amino acid supplementation will have a benefit effect on the muscular mass. That is testing the influence of the quality of protein consumed, more than the quantity. An anabolic substance (amino acid here) can lead to gain of muscle only if it is associated to regular physical training, all patients will follow a physical training.
Detailed Description
An excessive loss of lean mass could have negative metabolic consequences. Indeed, lean mass is an essential determinant of weight loss and of the glycaemia regulation. An important loss of muscular mass could expose the person to a reduction of quality of life (because of fatigue), or even a functional loss. Muscles are important for insulin sensibility and glucose metabolism. Muscles are proteolysis target and proteins will be used as sources of amino acid for other cellular functions.
Changes in lean mass have been at the centre of several studies, but changes in muscular mass after bariatric surgery have been report only one time.
A cohort study in the nutrition unit at Toulouse University Hospital shows that 3 months and 1 year after surgery, there are 2 phenotypes of patients. The first one is called 'little loss' and is defined by a contribution of muscular weight lower than 15% of the total weight loss. The other one is called 'big loss' and is defined by a contribution of muscular weight higher than 15% of the total weight loss. Causes of these different phenotypes are unknown for the moment. Nothing distinguishes them before the surgery. Type of surgery, gender, protein intake (in grams of proteins intake per day) do not appear to have a determining influence about the intensity of muscle mass loss. The only other study published shows changes in muscular mass about 15% at 6 weeks.
Relation between glycaemia changes and muscle mass changes suggests that patients with modest changes in muscular mass are patients who have the best improvement of glycaemia after surgery. It is the reason why, it could be interesting to preserve muscular mass.
Nowadays, there is no consensual strategy to compensate this loss of muscle mass. It is important to have in the same time an anabolic stimulus (training, hormone…) and a sufficient energy and protein intake.
According to a recent study which compares leucine intake with placebo during weight loss driven by a low-calorie diet associated to a muscle strengthening exercises, patients loss the same weight, but leucin group is gaining lean mass, while placebo group is losing it. Accordingly, twe different doses of amino acid will be tested of those used as diet supplement.
This study is testing the influence of the quality of protein consumed, more than the quantity. Patients will take leucine-enriched amino acid supplement and follow physical training. Aromatic amino acid supplementation showed an anabolic effect in older people, undernourished children and undernourished patients with chronic obstructive pulmonary disease. There are no known side effects. This amino acid supplementation has not been evaluated in post-obesity surgery context.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
Post-obesity surgery, Leucine-enriched amino acid supplementation, Anabolic substance, Physical training, Muscular mass, Loss of weight
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
6 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Leucine-enriched amino acid : 2.16g/day
Arm Type
Experimental
Arm Description
Dietary Supplement: Leucine-enriched amino acid supplementation and 30 minutes of physical training 3 times per week (2.16g/day)
Arm Title
Leucine-enriched amino acid : 4g/day
Arm Type
Experimental
Arm Description
Dietary Supplement: Leucine-enriched amino acid supplementation and 30 minutes of physical training 3 times per week (4g/day).
Intervention Type
Dietary Supplement
Intervention Name(s)
Leucine-enriched amino acid supplementation and 30 minutes of physical training 3 times per week
Intervention Description
After 3 months of obesity-surgery, if patients lost more than 15% of muscular weight, they will take a leucine-enriched amino acid supplementation during 3 months added with a regular physical training (30 minutes, 3 times/week). Arm A will take 2.46g/day of leucine-enriched amino acid supplementation and arm B 4g/day.
Primary Outcome Measure Information:
Title
Change from baseline in appendicular muscular mass at 3 months
Description
Appendicular muscular mass measured by dual-energy X-ray absorptiometry (DEXA). It will be measured before and 3 months after supplementation.
Time Frame
Baseline and 3 months
Secondary Outcome Measure Information:
Title
Change from baseline in limbs muscular force at 3 months
Description
The lower and higher limbs muscular force will be measured with a strain gauge.
Time Frame
Baseline and 3 months
Title
Change from baseline in muscular function at 3 months
Description
400 meters walking speed
Time Frame
Baseline and 3 months
Title
Change from baseline in muscular function at 3 months
Description
Chair-stand test
Time Frame
Baseline and 3 months
Title
Change from baseline in muscular function at 3 months
Description
Balance test by the Short Physical Performance Battery test
Time Frame
Baseline and 3 months
Title
Change from baseline in fatigue at 3 months
Description
Fatigue will be evaluate by the Pichot scale
Time Frame
Baseline and 3 months
Title
Change from baseline in general functional assessment at 3 months
Description
General function will be assessed by the Functional Status Questionnaire test.
Time Frame
Baseline and 3 months
Title
Change from baseline in protein daily intake at 3 months
Description
Patient will evaluate his/her protein daily intake (in g/day) by the Protein Intake Monitor with a digital tablet
Time Frame
Baseline and 3 months
Title
Change from baseline in physical training adhesion at 3 months
Description
Patients will have an exercise diary to write their organised physical activity. Physical activity will be converted in a multiple of basal metabolic rate.
Time Frame
Baseline and 3 months
Title
Change from baseline in glucose metabolism at 3 months
Description
Oral glucose tolerance test will be performed and glucose concentration will be determined into the blood.
Time Frame
Baseline and 3 months
Title
Change from baseline in insulin secretion at 3 months
Description
Oral glucose tolerance test will be performed and insulin concentration will be determined into the blood.
Time Frame
Baseline and 3 months
Title
Change from baseline in leucine compliance
Description
Leucine concentration and variation between visit before and after 3 months of supplementation will be measured by chromatography to assess the patient's compliance
Time Frame
Baseline and 3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient older than 18 years of age and younger than 65 years of age,
Patient received an obesity-surgery (gastric bypass or sleeve gastrectomy)
Contribution of muscular weight higher than 15% of the total weight loss after the third month post-surgery.
Patient that be able to increase their physical activity
Patient that give their informed consent before any procedure for the study
Patient affiliated with a health insurance scheme
Exclusion Criteria:
Patients allergic to one of the supplement's compound.
Patients with glucocorticoid therapy
Patients with hyperthyroidism
Patients commencing insulin treatment or growth hormone
Protein powder intake (as nutritional complement or as anabolic substance for muscle building practice)
Oral nutritional supplement intake for malnutrition
Bone fracture since the surgery
Infection can cause hypercatabolism (like microbial outbreak or chronic gastric fistula)
Hospitalization for more than 24 hours since the surgery
Known physical handicap
Inability to increase physical activity during 3 months after beginning of the supplementation
Enteral or parenteral nutrition
Patients over 158 kg (DEXA impossible)
Protected adults (guardianship by court order)
Pregnant woman or breastfeeding.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
RITZ Patrick, MD PhD
Organizational Affiliation
University Hospital, Toulouse
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Endocrinology, metabolic diseases and nutrition
City
Toulouse
ZIP/Postal Code
31059
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Study of Amino Acid Supplementation for Patients With an Excessive Loss of Muscular Body Mass After Obesity Surgery.
We'll reach out to this number within 24 hrs